Insightful Health Articles

94. Growing doubt on statin drugs — the problem of drug-lifestyle interaction

This is a repost with permission which has been written by Dr John Mandrola. I am very grateful to him for his agreement to publish here. He can be contacted via his web site which is at http://www.drjohnm.org/ Introduction My mind is changing about statins. I’m growing increasingly worried about the irrational exuberance over these

94. Growing doubt on statin drugs — the problem of drug-lifestyle interaction Read More »

90. Why is Nutrition in such a Mess?

I well remember all the hype surrounding the publication of the NACNE (National Advisory Committee on Nutrition Education) report in the early 1980s (1). The main thrust of this was that the national diet had deteriorated to such an extent that it was responsible for the relatively high level of chronic diseases, especially heart disease

90. Why is Nutrition in such a Mess? Read More »

89. Draft Scientific Advisory Committee on Nutrition (SACN) Report on Carbohydrates

After deliberating for 6 years we finally have the draft report on carbohydrates (1). In view of the current concern about the effects of sugar on health, there is likely to be considerable interest in the findings. The report consists of a comprehensive evaluation of the available scientific evidence which provides information on the role

89. Draft Scientific Advisory Committee on Nutrition (SACN) Report on Carbohydrates Read More »

88. The Guardian Tackles Obesity

In an article entitled “The shape we’re in” Guardian health editor Sarah Boseley presents “ten shocking facts about Britain’s health crisis” which claim to be the truth about obesity (1). Unfortunately she simply re-hashes the stale old arguments and false information, which is why we are in such a mess. There is no doubt that

88. The Guardian Tackles Obesity Read More »

86. A Case Study of Avandia

GlaxoSmithKline (GSK) was recently accused of offering substantial sums as bribes in order to facilitate sales of their products in China. This is not the first time the drug company has encountered problems because of behaviour which fails to match up to the highest standards of corporate social responsibility. In 2007 Steven Nissen and Kathy

86. A Case Study of Avandia Read More »

Scroll to Top
Share via
Copy link